Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Western blot analysis was performed on human plasma (5 ul) (Lane 1). The blots were probed with Mouse Anti-C1 Inhibitor Monoclonal Antibody (Product # LFMA0136, 0.5 ug/ml) and detected by chemiluminescence using Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, HRP conjugate (Product # A28177, 0.25 ug/ml, 1:4000 dilution). A 104 kDa band corresponding to C1 Inhibitor was observed across the samples tested. Known quantity of protein samples were electrophoresed using Novex® NuPAGE® 4-12 % Bis-Tris gel (Product # NP0321BOX), XCell SureLock™ Electrophoresis System (Product # EI0002) and Novex® Sharp Pre-Stained Protein Standard (Product # LC5800). Resolved proteins were then transferred onto a nitrocellulose membrane with iBlot® 2 Dry Blotting System (Product # IB21001). The membrane was probed with the relevant primary and secondary Antibody following blocking with 5 % skimmed milk. Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005).
|Tested species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||C1 inhibitor purified from human plasma.|
|Storage buffer||HEPES with 0.15M NaCl, 0.01% BSA, 50% glycerol|
|Contains||0.03% sodium azide|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunoprecipitation (IP)||2 µg|
|Western Blot (WB)||0.2-2 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
A suggested positive control for this product is human plasma.
C1 inhibitor (C1-INH) is a serine protease inhibitor that inactivates several different proteases in the complement, contact, coagulation, and fibrinolytic systems. Though C1-INH has 478 residues (53kDa), the circulating protein is approximately 104 kDa by post-translational modification. Deficiency of C1-INH results in hereditary angioedema. In addition, C1-INH may prove useful in a variety of other diseases including septic shock, reperfusion injury, hyperacute transplant rejection, traumatic and hemorrhagic shock.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
C1 esterase inhibitor; C1 Inh; C1-inhibiting factor; C1Inh; complement component 1 inhibitor; Plasma protease C1 inhibitor; serine/cysteine proteinase inhibitor clade G member 1; Serpin G1; serpin peptidase inhibitor clade G member 1; serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
C1IN; C1INH; C1NH; HAE1; HAE2; SERPING1